SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Effects of Ayahuasca and its Alkaloids on Drug Dependence: A Systematic Literature Review of Quantitative Studies in Animals and Humans
16 references·4 citing·39 second hop
Effects of Ayahuasca and its Alkaloids on Drug Dependence: A Systematic Literature Review of Quantitative Studies in Animals and Humans (2016)Effects of Ayahuasca and its Alkaloids on…The Psychedelic State Induced by Ayahuasca Modulates the Activity and Connectivity of the Default Mode Network (2015)The Psychedelic State Induced…Psilocybin-Occasioned Mystical Experiences in the Treatment of Tobacco Addiction (2015)Psilocybin-Occasioned Mystica…Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study (2015)Psilocybin-assisted treatment…Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report (2015)Antidepressant effects of a s…Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression (2015)Antidepressant Effects of a S…Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction (2014)Pilot study of the 5-HT 2A R …Ayahuasca-Assisted Therapy for Addiction: Results from a Preliminary Observational Study in Canada (2013)Ayahuasca-Assisted Therapy fo…Personality, Psychopathology, Life Attitudes and Neuropsychological Performance among Ritual Users of Ayahuasca: A Longitudinal Study (2012)Personality, Psychopathology,…Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects (2011)Psilocybin occasioned mystica…Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement (2010)Preferred reporting items for…Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Preferred reporting items for…Human Pharmacology of Ayahuasca: Subjective and Cardiovascular Effects, Monoamine Metabolite Excretion, and Pharmacokinetics (2003)Human Pharmacology of Ayahuas…5-HT Modulation of Dopamine Release in Basal Ganglia in Psilocybin-Induced Psychosis in Man—A PET Study with [11C]raclopride (1999)5-HT Modulation of Dopamine R…Human Psychopharmacology of Hoasca, A Plant Hallucinogen Used in Ritual Context in Brazil (1996)Human Psychopharmacology of H…Plants of the Gods: Their Sacred, Healing and Hallucinogenic Powers (1992)Plants of the Gods: Their Sac…The psychoanalytic review (1932)The psychoanalytic reviewAyahuasca use and reported effects on depression and anxiety symptoms: An international cross-sectional study of 11,912 consumers (2021)Ayahuasca use and reported ef…Ayahuasca and Public Health: Health Status, Psychosocial Well-Being, Lifestyle, and Coping Strategies in a Large Sample of Ritual Ayahuasca Users (2019)Ayahuasca and Public Health: …Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: a large, international, self-selecting online survey (2017)Well-being, problematic alcoh…AYAHUASCA V ČESKÉ REPUBLICE (2017)AYAHUASCA V ČESKÉ REPUBLICEHallucinogens (2004)Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance (2006)Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer (2010)Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness (2011)Psychedelics and the essential importance of context (2018)The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies (2007)Cochrane Handbook for Systematic Reviews of Interventions (2008)The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration (2009)The PRISMA 2020 statement: an updated guideline for reporting systematic reviews (2021)The PRISMA 2020 statement: an updated guideline for reporting systematic reviews (2021)The PRISMA 2020 statement: An updated guideline for reporting systematic reviews (2021)The varieties of religious experience: A study in human nature. (1902)Universals in the Content and Structure of Values: Theoretical Advances and Empirical Tests in 20 Countries (1992)Combining effect size estimates in meta-analysis with repeated measures and independent-groups designs. (2002)Neural correlates of the LSD experience revealed by multimodal neuroimaging (2016)Psilocybin with psychological support for treatment-resistant depression: six-month follow-up (2017)REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics (2019)Full Catastrophe Living: Using the Wisdom of Your Body and Mind to Face Stress, Pain, and Illness (2008)The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs (2014)Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder (2022)A RATING SCALE FOR DEPRESSION (1960)The Brief Psychiatric Rating Scale (1962)A New Depression Scale Designed to be Sensitive to Change (1979)Psychedelics as Medicines: An Emerging New Paradigm (2016)Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern‐era clinical studies (2020)The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration (2009)PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation (2018)Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin (2012)Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases (2014)Psychiatry & the psychedelic drugs. Past, present & future (2017)Blinding and expectancy confounds in psychedelic randomized controlled trials (2021)Predicting Responses to Psychedelics: A Prospective Study (2018)Emotions and brain function are altered up to one month after a single high dose of psilocybin (2020)Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up (2022)The Patient as Interpreter of the Analyst's Experience (1983)Toward a Theoretical Explanation of the Effects of Race on Counseling A Black and White Model (1984)The mental health of children affected by armed conflict: Protective processes and pathways to resilience (2008)Pharmacokinetics of Hoasca alkaloids in healthy humans (1999)The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act (2018)
this work references cited by second hop

References

  • 2009Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement83,813 cited
  • 2010Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement12,147 cited
  • 2015Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study1,150 cited
  • 2011Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects932 cited
  • 2014Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction913 cited
  • 1932The psychoanalytic review893 cited
  • 2015Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report485 cited
  • 2015Psilocybin-Occasioned Mystical Experiences in the Treatment of Tobacco Addiction475 cited
  • 1992Plants of the Gods: Their Sacred, Healing and Hallucinogenic Powers466 cited
  • 2015Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression465 cited
  • 2015The Psychedelic State Induced by Ayahuasca Modulates the Activity and Connectivity of the Default Mode Network454 cited
  • 2003Human Pharmacology of Ayahuasca: Subjective and Cardiovascular Effects, Monoamine Metabolite Excretion, and Pharmacokinetics390 cited
  • 1996Human Psychopharmacology of Hoasca, A Plant Hallucinogen Used in Ritual Context in Brazil338 cited
  • 2013

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

Ayahuasca-Assisted Therapy for Addiction: Results from a Preliminary Observational Study in Canada
330 cited
  • 2012Personality, Psychopathology, Life Attitudes and Neuropsychological Performance among Ritual Users of Ayahuasca: A Longitudinal Study313 cited
  • 19995-HT Modulation of Dopamine Release in Basal Ganglia in Psilocybin-Induced Psychosis in Man—A PET Study with [11C]raclopride304 cited
  • Cited by

    • 2017Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: a large, international, self-selecting online survey78 cited
    • 2019Ayahuasca and Public Health: Health Status, Psychosocial Well-Being, Lifestyle, and Coping Strategies in a Large Sample of Ritual Ayahuasca Users76 cited
    • 2021Ayahuasca use and reported effects on depression and anxiety symptoms: An international cross-sectional study of 11,912 consumers73 cited
    • 2017AYAHUASCA V ČESKÉ REPUBLICE6 cited